We've found
15,843
archived clinical trials in
Colorectal Cancer
We've found
15,843
archived clinical trials in
Colorectal Cancer
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Pre-op Rectal ChemoRad +/- Cetuximab
Updated: 11/7/2015
A Randomized Phase II Trial of Pre-operative Chemoradiotherapy With or Without Cetuximab (ERBITUX(R)) in Locally-advanced Adenocarcinoma of the Rectum
Status: Enrolling
Updated: 11/7/2015
Click here to add this to my saved trials
RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Updated: 11/11/2015
A Phase I/II Study of RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Status: Enrolling
Updated: 11/11/2015
RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Updated: 11/11/2015
A Phase I/II Study of RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Status: Enrolling
Updated: 11/11/2015
Click here to add this to my saved trials
RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Updated: 11/11/2015
A Phase I/II Study of RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Status: Enrolling
Updated: 11/11/2015
RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Updated: 11/11/2015
A Phase I/II Study of RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Status: Enrolling
Updated: 11/11/2015
Click here to add this to my saved trials
Faith-based Approaches to Treating Hypertension and Colon Cancer Prevention
Updated: 11/11/2015
Faith-based Approaches to Treating Hypertension and Colon Cancer Prevention
Status: Enrolling
Updated: 11/11/2015
Faith-based Approaches to Treating Hypertension and Colon Cancer Prevention
Updated: 11/11/2015
Faith-based Approaches to Treating Hypertension and Colon Cancer Prevention
Status: Enrolling
Updated: 11/11/2015
Click here to add this to my saved trials
A Prospective Trial of an Endoscopic Quality Improvement Project
Updated: 11/12/2015
A Prospective Randomized Controlled Trial of an Endoscopic Quality Improvement Project-2 (EQUIP-2) to Improve Adenoma Detection in Screening and Surveillance Colonoscopy
Status: Enrolling
Updated: 11/12/2015
A Prospective Trial of an Endoscopic Quality Improvement Project
Updated: 11/12/2015
A Prospective Randomized Controlled Trial of an Endoscopic Quality Improvement Project-2 (EQUIP-2) to Improve Adenoma Detection in Screening and Surveillance Colonoscopy
Status: Enrolling
Updated: 11/12/2015
Click here to add this to my saved trials
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Click here to add this to my saved trials
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Click here to add this to my saved trials
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Click here to add this to my saved trials
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Click here to add this to my saved trials
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Click here to add this to my saved trials
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Click here to add this to my saved trials
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Click here to add this to my saved trials
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Click here to add this to my saved trials
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Updated: 11/13/2015
A Phase II Trial of Irinotecan and AZD2171 in Patients With Metastatic Colorectal Cancer After Progression on First-Line Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Status: Enrolling
Updated: 11/13/2015
Click here to add this to my saved trials